Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

CTL recognize different determinants from those defined serologically on Ld somatic cell mutants.

J A Bluestone, T A Potter, S Chatterjee-Hasrouni

    Journal of Immunology (Baltimore, Md. : 1950)
    |September 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The Extra-Islet Pancreas Supports Autoimmunity in Human Type 1 Diabetes.

    medRxiv : the preprint server for health sciences·2023
    Same author

    Polyclonal Regulatory T Cell Therapy for Control of Inflammation in Kidney Transplants.

    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2017
    Same author

    Is there a role for MHC class I antigens in the elimination of somatic mutants?

    Immunology today·2014
    Same author

    Cell-surface molecules involved in T-cell functions.

    Immunology today·2014
    Same author

    The regulation of the immune system.

    Immunology today·2014
    Same author

    β2-microglobulin and MHC antigen expression.

    Immunology today·2014

    Researchers studied structural mutants of the Ld molecule to understand how cytotoxic T-lymphocyte (CTL) clones recognize targets. Most CTL clones recognized different sites than those targeted by antibodies, revealing distinct immune recognition pathways.

    Area of Science:

    • Immunology
    • Molecular Biology
    • Cell Biology

    Background:

    • Cytotoxic T-lymphocytes (CTLs) are crucial for adaptive immunity, mediating cellular responses against infected or cancerous cells.
    • The Ld molecule, a type of Major Histocompatibility Complex (MHC) class I molecule, presents antigens to T-cells.
    • Understanding the specificity of CTL recognition is vital for developing effective immunotherapies.

    Purpose of the Study:

    • To investigate the recognition specificities of allogeneic CTL clones against Ld structural mutants.
    • To determine the relationship between CTL recognition and antibody-defined serologic determinants on the Ld molecule.
    • To explore the utility of monoclonal antibody (mAb) blocking studies in defining CTL fine specificity.

    Main Methods:

    • Isolation and characterization of reciprocal Ld structural mutants from a somatic cell line.

    Related Experiment Videos

  • Testing of 36 allogeneic CTL clones on these Ld mutants.
  • Monoclonal antibody (mAb) blocking studies using anti-H-2 mAbs to inhibit CTL activity.

    • Main Results:

    • The majority of tested CTL clones recognized determinants distinct from those identified by antibody production.
    • Only a small subset of CTL clones (3 out of 36) recognized a determinant related to the negatively selected serologic determinant.
    • mAb blocking studies indicated that inhibition of CTL activity by anti-H-2 mAbs does not always accurately reflect the fine specificity of CTL recognition.

    Conclusions:

    • CTL clones and antibodies recognize different determinants on the Ld molecule, highlighting diverse immune recognition mechanisms.
    • The fine specificity of CTL recognition is complex and may not be fully elucidated by standard mAb blocking assays.
    • Further studies are needed to precisely map CTL epitopes on MHC molecules and understand their interactions with T-cell receptors.